ArticleFrontiers in oncology2022
Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring
Meng Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleFrontiers in oncology2022
Meng Fu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.